SciSparc Ltd. (NASDAQ:SPRC) Sees Large Growth in Short Interest

SciSparc Ltd. (NASDAQ:SPRC) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 1,030,000 shares, a growth of 1,435.0% from the February 28th total of 67,100 shares. Approximately 9.5% of the shares of the company are short sold. Based on an average daily volume of 9,770,000 shares, the days-to-cover ratio is presently 0.1 days.

SciSparc Price Performance

NASDAQ:SPRC traded down $0.01 during midday trading on Wednesday, hitting $0.31. The company’s stock had a trading volume of 276,808 shares, compared to its average volume of 3,741,995. SciSparc has a fifty-two week low of $0.20 and a fifty-two week high of $2.10. The firm’s 50 day moving average is $0.45 and its 200-day moving average is $0.35.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.